简介:摘要:近年来,经济的发展,促进我国科技水平的提升。随着社会的发展,科技的进步,电子产品、电器产品给人们的生活带来了极大的便利,但也带来了巨大的用电需求。同时,工业的发展也加大了对电能的消耗,这就给供电工作带来了新的挑战,自动化技术应用于电力系统,可以减少操作人员、管理人员的工作量,有利于提高电力系统的供电水平及稳定性,满足社会发展的用电需求。做好对电力系统的自动化运行维护,可以进一步提升电力系统的自动化水平,通过自动化技术实现对输配电及其用电工程的运行维护,可提高运维工作的工作效率,缩短电网的故障时间,进而减少故障带来的经济损失。本文就 输配电及用电工程的自动化运行维护展开探讨。
简介:摘要:2017年8月,环保局出台的《关于推进环境污染第三方治理的实施意见》(以下简称《意见》)中明确指出环境第三方治理的相关意见。《意见》明确指出水务、垃圾焚烧的领域应尽快地采用第三方治理模式,加快环境污染治理。国务院与国家环保局对环境污染第三方治理的意见推进了环境共用设施市场化,这为环境工程的建设与市场化运营提供了全新的机遇。根据《意见》要求,政府还对环境公共设施的投资通过政策上的引导与资金上的支持,大力支持企业投资建设环境工程,推动环境第三方治理的发展。研究环境工程设备中存在的问题和设备维护处理方案对环境第三法治理模式的高效实施有着重要的意义。
简介: 【摘要】目的:探究胺碘酮在急性心力衰竭合并快速心律失常患者治疗中的临床疗效与不良反应发生情况分析。方法:选取我院 2019年 1月 -2020年 5月我院收治的 86例急性心力衰竭合并快速心律失常患者为研究对象,采用随机分组的方法将其分为对照组和实验组,其中对照组急性心力衰竭合并快速心律失常患者进行常规治疗,而实验组患者在常规治疗的基础上联合胺碘酮进行治疗,对比两组的治疗有效情况和不良反应发生情况。结果:实验组急性心力衰竭合并快速心律失常患者在常规治疗的基础上联合胺碘酮治疗后,治疗有效率为 97.67%,优于对照组患者的治疗有效率( 83.72%),均 P<0.05,两组急性心力衰竭合并快速心律失常患者间数据差异明显,具有统计学意义。实验组急性心力衰竭合并快速心律失常患者在常规治疗的基础上联合胺碘酮治疗后,不良反应发生率为 11.63%;而对照组的不良反应发生率为 13.95%, P>0.05,两组急性心力衰竭合并快速心律失常患者间数据差异不明显,不具有统计学意义。结论:通过对急性心力衰竭合并快速心律失常患者在常规治疗的基础上联合胺碘酮进行治疗,可以明显提高临床治疗效果。 【关键词】急性心力衰竭 ;心律失常 ;胺碘酮 ;疗效 ;不良反应 Objective: To explore the clinical efficacy and adverse reactions of amiodarone in the treatment of patients with acute heart failure and tachyarrhythmia. Methods: 86 patients with acute heart failure complicated with tachyarrhythmia in our hospital from January 2019 to may 2020 were selected as the research objects, and they were randomly divided into the control group and the experimental group. The patients in the control group were treated with routine treatment, while the patients in the experimental group were treated with amiodarone on the basis of conventional treatment The effective situation and adverse reactions of the two groups were compared. Results: the experimental group of patients with acute heart failure and tachyarrhythmia combined with amiodarone on the basis of conventional treatment, the treatment effective rate was 97.67%, which was better than that of the control group (83.72%), both P < 0.05. There was significant difference between the two groups of patients with acute heart failure and tachyarrhythmia. In the experimental group, the incidence of adverse reactions was 11.63% in patients with acute heart failure combined with amiodarone on the basis of conventional treatment, while the incidence of adverse reactions in the control group was 13.95%, P > 0.05. There was no significant difference between the two groups of patients with acute heart failure and tachyarrhythmia. Conclusion: on the basis of conventional treatment, amiodarone combined with acute heart failure combined with tachyarrhythmia can significantly improve the clinical therapeutic effect.